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Abstract
Background:  Maxillary expansion (ME) is a common practice in orthodontics that aims to
increase the constricted maxillary arch width. Relapse often occurs, however, and better treatment
strategies are needed. In order to develop a more effective method, this study was designed to
further examine the process of tissue remodeling during ME, to identify the changes in expression
of several proteins of interest, and to clarify the molecular mechanism responsible for tissue
remodeling.
Methods: Male Wistar rats were randomly divided into control and ME groups. The rats were
euthanized at various intervals over 11 days, and the dissected palates were prepared for
histological examination. The structure of the midpalatal sutures changed little during the first three
days. Proteins from samples in the ground midpalatal tissues obtained on the third day were
subjected to two-dimensional polyacrylamide gel electrophoresis (2-DE) and matrix assisted laser
desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) analysis. Validation of
protein expression was performed by Western blot analyses.
Results: From day 5, chondrocytes in the inner layer of suture cartilage and osteoblasts at the end
of the suture cartilage began to proliferate, and the skeletal matrix increased later adjacent to the
cartilage in the ME group. Comparative proteomic analysis showed increases in 22 protein spots
present in the ME group. The changes in three proteins closely related to osteogenesis (parathyroid
hormone, osteoprotegerin and vimentin) were confirmed by Western blotting.
Conclusion: Many proteins are over-expressed during ME, and they may play an important role
in the remodeling process.
Background
Maxillary expansion (ME), or palatal expansion, is a com-
mon practice in orthodontics that aims to increase con-
stricted maxillary arch width. The procedure is often
performed to treat posterior crossbites, and is sometimes
used in instances of arch crowding, Angle Class I maloc-
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clusions with a V-shaped maxillary arch, and Angle Class
III malocclusions with a maxillary deficiency. However,
even after long-term retention is applied to prevent a
relapse, there is generally a reduction of the expanded
maxillary arch width to some extent [1].
Several studies in rats and other animals have been under-
taken to explore the mechanism of tissue remodeling in
order to improve the efficacy of ME. The expressions of
TGF-β1 [2], integrin and FAK [3] in ME have been eluci-
dated, and several adjunctive ME therapies have been pro-
posed including administration of TGF-β1 [2], low-power
laser irradiation [4], bisphosphonate [5], BMP-7 and Nell-
1 [6].
ME is a special form of sutural distraction osteogenesis in
which a mechanical force is transformed into a biological
stimulus, which initiates tissue remodeling and new bone
formation in the midpalatal suture. The complicated bio-
logical process may involve chondrocyte hypertrophy,
angiogenesis, absorption of original tissues in the suture,
and the formation of skeletal matrix. Many proteins may
contribute to the final results. Previous studies have been
limited to investigating one or a few proteins, but the
complex biological mechanism of ME necessitates the use
of a global proteomic analysis to improve the understand-
ing of the process in greater detail.
Proteomics is the study of all proteins expressed by
genomes, and provides a global analysis of complex pro-
tein mixtures. Proteomic methodologies for differentially
expressed profiles of tissue proteins from the midpalatal
sutures of a ME group and a control group may provide
clues about the biological functions of these proteins dur-
ing ME. The present study was designed to obtain a further
understanding, via differential proteomics evaluations, of
tissue remodeling during ME and to determine whether
any proteins are differentially expressed, and whether
these proteins are related to the observed tissue remode-
ling.
Methods
Experimental animals
Six-week-old male Wistar rats were procured from the
Shanghai SLAC Laboratory Animal Co. Ltd and bred in
the Nanjing Medical University Animal Center
(NJMUAC). The pre-operative and post-operative care of
these animals was overseen by NJMUAC veterinarians to
ensure proper and humane treatment. The rats were all fed
commercial pellet food with water ad libitum, and were
housed in cages under controlled conditions at 25°C on a
12h:12h light/dark cycle (light cycle starting at 7:00 a.m.).
The health status of each rat was evaluated by daily body
weight monitoring. Approval for the study was obtained
from the Animal Ethics Committee of Nanjing Medical
University.
ME procedure
The rats were randomly divided (RandA1.0 Software,
Planta Medical Technology and Development Co. Ltd,
Beijing, PR China) into an experimental ME group and a
control group (52/group). After being anesthetized by an
intraperitoneal injection of sodium pentobarbital at 50
mg/kg body weight, the 52 rats in the experimental group
received the ME operation. Briefly, a 1.5 mm thick circular
stainless steel expander ring was inserted between the
maxillary incisors and held by a 0.2 mm diameter round
wire on the first day of the experiment using the method
reported in previous studies [2,4]. From each group,
Twenty-eight rats were randomly selected for subsequent
histological examination and 24 for two-dimensional
polyacrylamide gel electrophoresis (2-DE).
Histological examination
Four rats from each group were euthanized by overdoses
of sodium pentobarbital at various times: before opera-
tion (0 d), or 1 d, 3 d, 5 d, 7 d, 9 d and 11 d after the oper-
ation. The midpalatal suture tissues were dissected and
the specimens obtained were decalcified, paraffin-embed-
ded, sectioned and stained with haematoxylin-eosin and
Masson's trichrome before examination under a micro-
scope.
Immunohistochemical analysis
The paraffin sections were dewaxed and pre-treated with
3% hydrogen peroxide. Expression of proliferation cell
nuclear antigen (PCNA) and Collagen I were detected
using the Streptavidin-Biotin-Peroxidase Complex
(SABC) immunohistochemical method (PCNA SABC kit,
Boster Biotechnology, Wuhan, PR China). The goat anti-
rat Collagen I monoclonal antibody was obtained from
Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Two-dimensional polyacrylamide gel electrophoresis (2-
DE)
The health status of the rats in the ME group was evaluated
by monitoring daily body weights that were recovered
from the third day (Fig 1). Since significant histological
changes in the sutures were observed starting on the fifth
day after operation, we chose to perform the proteomic
analysis of the midpalatal sutures 3 d after the operation
(24 rats/group) to evaluate which proteins might be
responsible for the observed structural changes. The rats
were euthanized as described above and the midpalatal
suture tissues were dissected and stored on ice. The fresh
tissue specimens were rinsed in ice-cold 0.01 M PBS buffer
solution, and then ground into powder in liquid nitrogen.
Proteins were extracted by suspending the tissue powder
in a sample buffer (7 M urea, 2 M Thiourea, 4% CHAPS,BMC Musculoskeletal Disorders 2008, 9:37 http://www.biomedcentral.com/1471-2474/9/37
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100 mM DTT, 40 mM Tris, 1 mM PMSF) at room temper-
ature and vortexing for 2 min. They were then stored at
4°C overnight. The supernatant was concentrated by
using a ReadyPrep 2-D Cleanup Kit (Bio-Rad, Hercules,
USA), removing impurities such as salts. The sediments
were re-dissolved in a sample buffer (7 M urea, 2 M Thiou-
rea, 4% CHAPS, 100 mM DTT, 40 mM Tris, 1 mM PMSF,
0.2% Carrier Ampholyte (pH 3–10), trace of bromophe-
nol blue) and incubated at room temperature for 2 h. Pro-
tein concentrations were determined by the Bradford
protein assay (Bio-Rad).
First-dimension isoelectric focusing (IEF) was performed
with precast 17-cm immobilized pH gradient (IPG) strips
(17 cm ReadyStrip IPG Strip 3–10 NL, Bio-Rad). Three
protein samples from each group were loaded, respec-
tively, onto the PROTEAN IEF Focusing Tray (Bio-Rad)
containing 300 μl of a mixture of the rehydration buffer
(7 M urea, 2 M Thiourea, 4% CHAPS, 100 mM DTT, 0.2%
Carrier Ampholyte (pH 3–10), trace of bromophenol
blue) and the sample buffer containing 80 μg protein.
After in-gel rehydration at 20°C for 12 h, proteins were
focused at 250 V at linear ramp for 0.5 h, 1,000 V at rapid
ramp for 1 h, 10,000 V at linear ramp for 5 h, and 10,000
V at rapid ramp for 6 h. All of the above procedures were
performed at 20°C. Immediately after IEF, the IPG strips
were equilibrated in the first equilibration buffer (6 M
urea, 2% SDS, 375 mM Tris-HCl (pH 8.8), 20% glycerol,
2% (w/v) DTT) for 15 min, and the second equilibration
buffer (6 M urea, 2% SDS, 375 mM Tris-HCl (pH 8.8),
20% glycerol, 2.5% (w/v) iodoacetamide) for another 15
min.
After the IPG Strips were rinsed with the 1 × Tris-glycine-
SDS running buffer, they were placed on 12% SDS-PAGE
gels and sealed with 1% LowMelt agarose. Second-dimen-
sion SDS-PAGE was carried out in a PROTEAN Plus
Dodeca Cell (Bio-Rad) at 100 V for 0.5 h, followed by
electrophoresis at 200 V, until the bromophenol blue
front reached the bottom of the gels. The protein spots on
the gels were fixed and visualized by silver staining and
scanned at 600 dpi. Analysis of the gel images for differen-
tially-expressed proteins was carried out using PDQuest
v7.3 software (Bio-Rad, Hercules, USA).
Mass spectrometry analysis and protein identification
The differentially-expressed protein spots were manually
excised into 1-mm2 pieces from the silver-stained gels. The
gel pieces containing the protein spots were destained by
rinsing three times with 25 mM ammonium bicarbonate
in 50% (v/v) acetonitrile for 45 min each. They were dried
at 50°C for 20 min, then subjected to in-gel digestion
with 30 μl of digestion solution (12.5 μg/ml trypsin in 25
mM ammonium bicarbonate) at 37°C for 16 h.
The peptides were concentrated by vigorous shaking at
room temperature, using a modification of the method
developed by Shevchenko [7]. Briefly, 30 μl of 25 mM
ammonium bicarbonate was added to the digestion solu-
tion mixture for 15 min, followed by the addition of 30 μl
of 100% (v/v) acetonitrile for another 15 min, after which
the supernatant was collected. The extraction procedure
was repeated two more times with 5% (v/v) formic acid in
100% (v/v) acetonitrile. The supernatants were pooled
and dried in a Speed-Vac (Thermo Savant, Holbrook,
USA). The extracted peptides were then re-dissolved in 20
μl of 2% (v/v) formic acid. The peptide fingerprint spectra
of proteins were obtained by matrix-assisted laser desorp-
tion/ionization-time of flight mass spectrometry (MALDI-
TOF MS, Bruker Inc, Billerica, USA) and were identified in
the rattus protein database using the MASCOT search
engine [8]. The Swiss-Prot, Trembl and NCBI databases
were used to obtain further information about the pro-
teins identified.
Validation by Western blot
Twenty-two proteins were detected whose expression was
substantially increased in the ME group by 2-DE and
MALDI-TOF MS. Among them, three proteins (parathy-
roid hormone (PTH), osteoprotegerin (OPG), and vimen-
tin) may have an important role in the development of
osteogenesis and therefore were chosen for validation by
Western blot analysis. Western blotting was performed as
described previously [9]. The initial sample for immuno-
blotting was prepared in the same way as for 2-DE. β-actin
was used as a loading control. The separated proteins were
incubated overnight with primary anti-PTH, anti-OPG
and anti-vimentin antibodies (Santa Cruz Biotechnology,
CA, USA). The blots were then incubated with peroxidase-
conjugated secondary antibody (1:2,000). Protein bands
were visualized using an enhanced chemiluminescence
system (Supersignal West Pico Trial Kit, Pierce, Rockford,
USA) and the density of each band was quantified with a
Fluor-S MultiImager (Bio-Rad). The experiment was per-
formed with samples from six rats in each group and the
mean expression level for each protein was calculated
accordingly.
Results
Effect of ME on body weight
Compared with the control group, the body weights of the
rats in the ME group decreased during the first two days
after operation and started recovering on the third day
(Figure 1). The average weights of the rats in the two
groups were significantly different from the second day to
the end of the experiment (P < 0.05). However, there was
only an approximately 5% difference in the mean weights
of the two groups at the end of the study period. This
small difference was caused by initial weight loss in the
ME group during the first two days as a result of the exper-BMC Musculoskeletal Disorders 2008, 9:37 http://www.biomedcentral.com/1471-2474/9/37
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imental procedure. There were no statistically significant
differences between the two groups in daily weight gain
from the second day (P > 0.05).
Histological alterations in the midpalatal sutures caused 
by ME
In the control group, histological observations of the
sutures showed no remarkable changes throughout the
study (Figs 2A, B), and were similar to the sutures of rats
in the ME group on day 0 (Figure 2C). In the ME group,
during the first three days after operation, there were no
significant changes in the the cellular composition and
structure of the midpalatal sutures (Figs 2C, D, E). But,
starting on day 5 there was significant tissue remodeling
observed in the sutures of the ME group, including
absorption of suture cartilage and invasion of new tissue
(Figs 2F, G, H). Masson's trichrome staining showed that
more newly-formed skeletal matrix was present between
the cartilage and bone in the ME group than in the control
group (Figure 3), indicating a critical role of endochon-
dral ossification in the ME process.
PCNA and Collagen I expression
During the first three days, few PCNA-positive cells were
observed in either group. From day 5, some of the
chondrocytes in the inner layer of suture cartilage and
osteoblasts at the end of the suture cartilage were PCNA
positive in the ME group (Figure 4). On day 11, many
osteoblasts adjacent to bone trabeculae were positive in
the ME group (Figure 4). To identify the tissue (marked
with "T") in the suture shown in Figure 2H of the ME
group, we performed immunohistochemical analysis of
Collagen I and found that it was bone tissue, but not
residual suture cartilage (Figure 5).
2-DE, MALDI-TOF MS and protein identification
There were 1862 (SD = 51.35) and 1944 (SD = 73.96) pro-
tein spots observed in gels from the control and ME
groups, respectively. The number of spots detected in each
set of three replicates was reproducible (coefficient of var-
iation, CV 13–29%), as was their spot intensity (CV
21–39%). Following analysis with the PDQuest software,
we selected 22 spots where the differentially-expressed
proteins were more abundant in the ME group, for further
analysis with MALDI-TOF MS. These 22 spots are marked
with arrows in Figure 6. The proteins contained in the 22
spots were identified by MALDI-TOF MS on the basis of
peptide mass matching. The identified proteins are listed
in Table 1.
Western blot analysis
As illustrated in Figure 7, the levels of PTH, OPG and
vimentin proteins in the midpalatal suture tissues of the
ME group were confirmed to be significantly higher than
those in the control group (P < 0.01).
Discussion
When stress is loaded onto the midpalatal suture, the
mechanical force is transformed into a biological signal
that results in a series of biological events, such as
chondrocyte hypertrophy, angiogenesis, cartilage and
other tissue resorption, skeletal matrix formation, and
matrix calcification. Finally, mechano-transducted osteo-
genesis occurs and the maxillary arch is expanded.
Numerous proteins are involved in these processes, and
Changes in rat body weight in the control and ME groups Figure 1
Changes in rat body weight in the control and ME groups. ME, Maxillary Expansion group. Control, untreated animals.BMC Musculoskeletal Disorders 2008, 9:37 http://www.biomedcentral.com/1471-2474/9/37
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Photomicrographs of midpalatal sutures during ME Figure 2
Photomicrographs of midpalatal sutures during ME. A: 0 d control group, B: 9 d control group, C: 0 d ME group, D: 1 d ME 
group, E: 3 d ME group, F: 5 d ME group, G: 7 d ME group, and H: 9 d ME group. SC: suture cartilage. SB: suture bone. There 
were no significant differences between the two groups in the tissue structure of the midpalatal sutures before day 5, but from 
day 5 until the end of the study, there was significant tissue remodeling observed in the sutures of the ME group that was not 
observed for the control animals. (Haematoxylin-eosin, original magnification ×40). The tissue marked " T " was further valida-
tion as bone or cartilage by determination of Collagen I localization (Figure 5).BMC Musculoskeletal Disorders 2008, 9:37 http://www.biomedcentral.com/1471-2474/9/37
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there is an urgent need to identify and characterize these
critical proteins. Proteomics is the study of the function of
all expressed proteins, i.e., the study of the proteome.
Compared with the genome, the proteome not only varies
by cell type, but also is dynamic in different physiological
states within the same cell.
Rats are often used as an animal model of ME [2,4,6]
based on economical and technical considerations. In the
present study, there was an additional reason to use the rat
model: contrary to the paucity of proteomic databases
applicable to some other animals such as dogs and cats,
the availability of the rat proteomic database would allow
us to identify interesting proteins based on the MS results.
PCNA expression in the midpalatal suture Figure 4
PCNA expression in the midpalatal suture. SC: suture cartilage. SB: suture bone. On day 5, some of the chondrocytes in the 
proliferating layer of the suture cartilage and osteoblasts at the end of the cartilage were PCNA-positive in the ME group. On 
day 11, many osteoblasts adjacent to the bone trabeculae were positive in the ME group. (Original magnification ×40).
Photomicrographs of the midpalatal sutures on day 5 Figure 3
Photomicrographs of the midpalatal sutures on day 5. SC: suture cartilage. SB: suture bone. Much more skeletal matrix (purple) 
is present adjacent to the suture cartilage in the ME group than in the control group. (Masson's trichrome, original magnifica-
tion ×40).BMC Musculoskeletal Disorders 2008, 9:37 http://www.biomedcentral.com/1471-2474/9/37
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The present study was undertaken to elucidate the changes
in the proteome between non-stressed suture tissues and
their counterparts subjected to mechanical stresses. The
data compiled in Table 1 suggest that several biological
processes were affected. The selected proteins that may
participate in the up-regulation of these biological proc-
esses are discussed below.
A: 2-DE map from an expanded midpalatal suture in the ME group Figure 6
A: 2-DE map from an expanded midpalatal suture in the ME group. The labeled proteins are differentially expressed. B: 2-DE 
map from a midpalatal suture in the control group. (pI: Isoelectric point. kDa: kilodalton. Mr: Molecular weight).
Collagen I expression in the expanded midpalatal suture 9 days after operation Figure 5
Collagen I expression in the expanded midpalatal suture 9 days after operation. The tissue in the suture (marked "T") from Fig-
ure 2H of the ME group is Collagen I-positive, indicating that it is bone, and not residual suture cartilage. (Original magnification 
×40).BMC Musculoskeletal Disorders 2008, 9:37 http://www.biomedcentral.com/1471-2474/9/37
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Osteogenesis
There are two main types of osteogenesis, endochondral
and intramembranous ossifications. Some investigators
suggest that intramembranous ossification is important to
mid-palatal suture expansion [10]. Based on HE staining
and immunohistochemical analysis of PCNA, we found
that following exposure to mechanical stress, osteoblasts
proliferated between the cartilage and periosteum. This
cartilage was gradually absorbed and replaced by bone
and connective tissue, indicating that intramembranous
ossification by osteoblasts from the palatal periosteum
plays an important role in ME. In addition, using Mas-
son's staining, we observed considerable skeletal matrices
adjacent to the suture cartilage, suggesting that endochon-
dral ossification contributes to osteogenesis in the early
stage of ME. Thus, both types of osteogenesis participate
in the tissue remodeling process during ME.
Several proteins, which were observed to change follow-
ing exposure to the mechanical stress, deserve additional
discussion. First, osteoprotegerin (OPG) is a soluble
'decoy' receptor that binds to RANKL (Receptor Activator
for NF-kB Ligand) and prevents it from binding to RANK
(Receptor Activator for NF-kB) [11]. This effectively inhib-
its RANKL-mediated osteoclast maturation. The balance
between the osteoclast-promoting RANKL and the osteo-
Table 1: Changes in protein expression observed in the expanded midpalatal suture.
Spot No. Identified Protein Accession 
Number
Calculated 
pI value
Nominal 
mass (Mr)
Number of 
Matched 
Peptides
Sequence 
Coverage
Fold 
Change
Mascot 
Score
Functional 
Category
2 Parathyroid hormone 
(PTH)
P04089 9.63 12722 7 71% 4.4 60 Osteogenesis
10 Annexin A2 (Annexin II) 
(Lipocortin II)
Q07936 7.53 38808 21 53% 10.2 131 Osteogenesis
11 Cartilage glycoprotein 39 
(GP-39)
Q9WTV1 8.93 42708 5 28% 3.6 54 Osteogenesis
14 Osteoprotegerin (OPG) O08727 8.79 47588 14 24% 4.1 57 Osteogenesis
21 Elongation factor 2 (EF-2) P05197 6.42 96061 12 15% 42.8 59 Osteogenesis
6 GTP-binding protein RAB-
3D
Q63942 4.75 24503 5 35% 3.0 57 Tissue resorption
18 Serine/threonine-protein 
kinase (PAK 1)
P35465 5.63 60825 10 27% 8.2 83 Tissue resorption 
and reconstruction 
of cytoskeleton
22 Deubiquitinating protein 
VCIP135
Q8CF97 6.77 135793 15 15% 3.6 55 Tissue resorption
5 Transgelin 2 (SM 22β) Q5XFX0 8.41 22550 9 34% 14.3 54 Angiogenesis
7 Growth factor receptor-
bound protein 2 (GRB2 
adapter protein)
P62994 5.89 25304 7 40% 23.6 63 Angiogenesis
16 Vimentin P31000 5.06 53626 13 27% 3.1 65 Angiogenesis and 
reconstruction of 
cytoskeleton
20 78 kDa glucose-regulated 
protein precursor (GRP 78)
P06761 5.07 72473 17 21% 3.8 100 Unfolded protein 
response
15 Adenylyl cyclase-associated 
protein 1 (CAP 1)
Q08163 7.30 51726 11 24% 4.0 54 Stress reaction and 
reconstruction of 
cytoskeleton
4 Adenylate kinase isoenzyme 
1 (ATP-AMP 
transphosphorylase) (AK1)
P39069 7.71 21645 9 44% 3.7 62 Energy metabolism
8 L-xylulose reductase Q920P0 6.82 25931 8 38% 6.5 61 Energy metabolism
12 Phosphoglycerate kinase 1 P16617 7.52 44794 10 29% 5.8 59 Energy metabolism
13 Alpha-enolase (ENO-1) AAH63174 6.16 47309 13 34% 7.6 79 energy metabolism
17 ATP synthase alpha chain P15999 9.22 59831 20 30% 4.8 110 Energy metabolism
1 Forkhead box protein D4 
(FOXD4)
Q63249 10.61 11905 5 59% 5.2 52 Cell proliferation
3 PP5-TPR variant Q80UF5 8.45 14325 8 56% 4.9 55 Cell proliferation
9 Psmd8 protein AAI05895 6.05 32545 11 31% 4.3 66 Protein synthesis
19 APOBEC1 
complementation factor
Q923K9 8.81 65864 10 20% 6.6 61 RNA editing
pI = Isoelectric point. Mr = Molecular weightBMC Musculoskeletal Disorders 2008, 9:37 http://www.biomedcentral.com/1471-2474/9/37
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clast-inhibiting OPG can regulate the number and activity
of osteoclasts. Annexin A2 (Annexin II, ANXA2) is a mem-
ber of the calcium-dependent phospholipid-binding pro-
tein family. It regulates cell growth, and is involved in
signal transduction pathways. It is also important for alka-
line phosphatase activity in bone and is associated with
osteoblast mineralization [12].
Parathyroid hormone (PTH) is produced almost exclu-
sively by the parathyroid glands and is transported to tar-
get tissues through blood circulation. The anabolic action
of PTH on cortical and cancellous bone has been vali-
dated [13]. The increased PTH levels in ME tissues may be
associated with increased local vascular density and/or a
rising concentration of serum PTH. Nevertheless, while
PTH likely plays a role in tissue remodeling, it remains to
be determined whether circulating endocrine hormones
(such as PTH) or local cytokines (such as OPG and bone
morphorgenic protein (BMP)) play the initial and key role
in ME.
Elongation factor 2 (EF 2) belongs to the G-protein super-
family and catalyzes the translocation step of translation
elongation after peptide bond formation occurs. It con-
tributes to the differentiation of chondrocytes to the
hypertrophic stage, which is essential for endochondral
ossification [14]. Its presence suggests participation of
endochondral ossification in osteogenesis during ME.
Cartilage glycoprotein 39 (GP-39) is produced by several
types of human cells, including chondrocytes, synovial
cells, macrophages, and neutrophils [15]. It is highly
expressed in osteoarthritic synovial fluids and osteophytic
tissues and may be a more accurate marker of chondrocyte
activation in the disease process. This protein may partic-
ipate in endochondral ossification and matrix resorption.
These five proteins were all up-regulated in the early stage
of ME, and at least some of them may be responsible for
the effects of ME. Future studies are needed to determine
the effects of these on various types of osteogenesis, such
as distraction osteogenesis in long bones, and the healing
of bone fractures.
Tissue resorption
In many circumstances, new bone formation is accompa-
nied by bone resorption, and osteogenesis results from a
change in the equilibrium between osteoclasts and oste-
oblasts. In the earlier stage of ME, resorption predomi-
nates, and some of the proteins listed in Table 1 may be
important for this process. For instance, PAK1 can medi-
ate osteoclasts through its involvement in the organiza-
tion of the actin cytoskeleton, thereby regulating their
resorptive activity [16]. In the present study, we found that
PAK1 was up-regulated, suggesting increased osteoclast
activity. Ras-related protein (RAB-3D) is involved in vesic-
ular traffic and regulates the release of catabolic enzymes
during bone resorption [17]. Deubiquitinating protein
(VCIP135) is also involved in vesicular traffic [18]. The
mechanisms by which the resorption of other tissues is
regulated in the mid-palatal suture are not clear, and fur-
ther studies of how these two proteins participate in tissue
resorption are required.
A: Representative Western blots for the expression analyses of OPG, PTH and vimentin Figure 7
A: Representative Western blots for the expression analyses of OPG, PTH and vimentin. β-actin was used as the loading con-
trol. (OPG: osteoprotegerin. PTH: parathyroid hormone). B: The OPG, PTH and vimentin protein levels relative to β-actin 
protein levels were assessed by densitometric analysis, and expressed in the ME group relative to the same three proteins in 
the control group. (*The level in ME animals was significantly higher than the respective controls, P < 0.01).BMC Musculoskeletal Disorders 2008, 9:37 http://www.biomedcentral.com/1471-2474/9/37
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Angiogenesis
Angiogenesis is a pivotal process in osteogenesis, which
regulates cell proliferation, differentiation, and bone for-
mation and resorption. Transgelin 2 is one of the earliest
markers of differentiated smooth muscle, and is expressed
in smooth muscle cells and mesenchymal stem cells.
Vimentin is a member of the intermediate filament family
of proteins. Both transgelin 2 and vimentin have been
identified as proteins that regulate angiogenesis [19-21].
Overexpression of GRB2, another molecule identified
during our study, enhances VEGF-dependent cell migra-
tion and is regarded as a regulator of VEGF [22]. Based on
these findings, we speculate that the induction of these
three pro-angiogenic genes may support new vasculature
for bone induction during ME.
Other processes
Unfolded protein response (UPR) and stress reaction
UPR is a function of the endoplasmic reticulum (ER) that
retains and finally degrades unfolded or mis-folded pro-
teins, and provide strict quality control to ensure that only
properly folded proteins are transported to the Golgi
apparatus. UPR activity is regulated by a complex system,
which includes the 78 kDa glucose-regulated protein
GRP78 [23]. Cyclase-associated protein (CAP) is a multi-
functional protein related to the stress reaction. The N-ter-
minal region is required for RAS2Val-19-dependent heat
shock sensitivity, while the C-terminal region is required
for normal cell morphology and responsiveness to nutri-
ent deprivation and excess [24]. Since ME is the applica-
tion of mechanical stress to skeletal sutures followed by
the induction of osteogenesis, an ER stress reaction should
be one of the first processes induced by the mechanical
stress. In the present study, the up-regulation of CAP that
we observed may be an indication of the stress reaction,
and the expression of GRP78 in the ME group indicates
that this may be critical during the early period of expan-
sion in order to ensure the proper assembly of proteins
and, ultimately, the proper function of suture cells.
Energy metabolism
There are five proteins listed in Table 1 that are involved
with energy metabolism including L-xylulose reductase
[25], alpha-enolase (ENO1) [26], adenylate kinase isoen-
zyme 1 (AKI) [27], phosphoglycerate kinase 1 [28], and
ATP synthase [29]. Many physiological processes are
accompanied by an increase in energy metabolism,
including tissue resorption, angiogenesis and osteogene-
sis, such as are observed during ME. Virtually all animal
cells and tissues shift to some extent from mitochondrial
respiration to anaerobic glycolysis for energy production
when exposed to hypoxic conditions. The pattern of respi-
ration/glycolysis during ME should be further examined
to determine the effects of this stress on the suture cells.
Cell proliferation
Proliferation and migration of mesenchymal stem cells,
osteoclasts, osteoblasts and fibroblasts are prerequisites
for tissue resorption, angiogenesis and osteogenesis in
ME. In the present study, on the fifth day after the opera-
tion, part of the chondrocytes in the proliferating layer of
the suture cartilage, and the osteoblasts at the end of the
cartilage were PCNA-positive in the group undergoing
ME. On the eleventh day after the operation, many oste-
oblasts adjacent to the bone trabeculae were positive in
the ME group. The proliferation of these cells was mainly
related to osteogenesis. Protein serine/threonine phos-
phatase PP5 is the prototype of the fourth subfamily of
the PPP family of protein phosphatases. Up-regulation of
PP5 in rapidly growing cells, as compared to serum-
deprived cells, suggests that it has a role in cell growth
[30]. FOXD4 is a novel winged helix transcription factor
belonging to the Forkhead-box (FOX) family, which plays
an important role in embryonic development, cell cycle
regulation, and oncogenesis [31]. These proteins might
initiate or promote the proliferation of cells such as
chondrocytes and osteoblasts.
Reconstruction of the cytoskeleton
As a key component of the intermediate filaments
cytoskeleton, vimentin contributes to the maintenance of
cell shape, migration, and response to mechanical stress
[32]. p21-activated kinase 1 (PAK1) and cyclase-associ-
ated protein (CAP) also participate in the construction of
the cytoskeleton [33,34]. In the mechanically-expanded
mid-palatal suture, the cytoskeleton should function in
the various processes of tissue remodeling, although the
underlying mechanism is still unclear.
Conclusion
Alterations in proteins and protein abundance, which
encompass numerous cellular protein networks and func-
tional networks, occur in the expanded midpalatal suture
following ME. The profile of protein alterations suggests
that the changes in the unfolded protein response and
stress reaction, energy metabolism, angiogenesis, cell pro-
liferation, reconstruction of the cytoskeleton, tissue
resorption, and osteogenesis are involved in tissue remod-
eling during maxillary expansion. Moreover, many of
these proteins have not been reported in skeletal tissues,
and understanding their functions requires further study
in order to determine their potential for developing opti-
mal clinical treatment approaches.
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